Tumor necrosis factor-alpha-induced cell death in U373 cells overexpressing alpha-synuclein

J Neurosci Res. 2003 Aug 1;73(3):334-40. doi: 10.1002/jnr.10662.

Abstract

Intracellular alpha-synuclein inclusion formation in glial cells is frequently seen in Parkinson's disease and multiple system atrophy. Microglial activation in these neurodegenerative disorders suggests that neuroinflammatory responses might interact with alpha-synuclein and contribute to the pathogenesis of these disorders. To study the role of tumor necrosis factor-alpha (TNF-alpha), an important proinflammatory cytokine produced by microglia, on cells overexpressing alpha-synuclein we have used the astrocytoma cell line U373 engineered to express C-terminally truncated alpha-synuclein as a fusion protein with red or green fluorescent proteins. We demonstrate that alpha-synuclein overexpression augmented TNF-alpha-induced apoptotic cell death in U373 cells by induction of caspase activation. Furthermore, TNF-alpha exposure was associated with significant cytoskeletal changes characterized by altered inclusion composition with loss of cytoskeletal proteins and elevation of high-molecular-weight alpha-synuclein species. We conclude that alpha-synuclein overexpression significantly increases the vulnerability of U373 cells to apoptosis through TNF-alpha-mediated pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Brain Neoplasms*
  • Cytoskeleton / physiology
  • Gene Expression
  • Glioblastoma*
  • Humans
  • Nerve Tissue Proteins / genetics*
  • Synucleins
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology
  • alpha-Synuclein

Substances

  • Antineoplastic Agents
  • Nerve Tissue Proteins
  • SNCA protein, human
  • Synucleins
  • Tumor Necrosis Factor-alpha
  • alpha-Synuclein